Entyvio Injection and Insulin Glargine (U-300) Pens
Determining the interaction of Entyvio Injection and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: vedolizumab
Brand name: Entyvio
Synonyms: Vedolizumab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Entyvio Injection-Insulin glargine and lixisenatide
- Entyvio Injection-Insulin glargine and lixisenatide Subcutaneous
- Entyvio Injection-Insulin glargine, recombinant Subcutaneous
- Entyvio Injection-Insulin glulisine
- Entyvio Injection-Insulin Glulisine (Cartridges and Pens)
- Entyvio Injection-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Enulose
- Insulin Glargine (U-300) Pens-Envarsus XR
- Insulin Glargine (U-300) Pens-Enzalutamide
- Insulin Glargine (U-300) Pens-Enzoclear Foam
- Insulin Glargine (U-300) Pens-Eolarix
- Insulin Glargine (U-300) Pens-Eovist